Pulmonary function testing in COPD: looking beyond the curtain of FEV1
Abstract Chronic obstructive pulmonary disease (COPD) management remains challenging due to the high heterogeneity of clinical symptoms and the complex pathophysiological basis of the disease. Airflow limitation, diagnosed by spirometry, remains the cornerstone of the diagnosis. However, the calcula...
Guardado en:
Autores principales: | Sotirios Kakavas, Ourania S. Kotsiou, Fotis Perlikos, Maria Mermiri, Georgios Mavrovounis, Konstantinos Gourgoulianis, Ioannis Pantazopoulos |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cc06a18eb8ea416582606caa139086d6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Underestimation of respiratory symptoms by smokers: a thorn in chronic obstructive pulmonary disease diagnosis
por: Evdoxia Gogou, et al.
Publicado: (2021) -
Blood Eosinophils and Pulmonary Rehabilitation in COPD
por: Jafar Aljazeeri, et al.
Publicado: (2021) -
PeakPCO combined with FEV1/FVC predicts vasodilator-responsive patients with idiopathic pulmonary arterial hypertension
por: Ci-Jun Luo, et al.
Publicado: (2021) -
FeV1 and BMI influence King’s Sarcoidosis Questionnaire score in sarcoidosis patients
por: Björn Christian Frye, et al.
Publicado: (2021) -
Mepolizumab and COPD in Real Life
por: Fernando Revuelta-Salgado, et al.
Publicado: (2022)